Denise Pretzer

Title: Denise Pretzer - Innovator in Oral Liquid Formulations for Bone Health

Introduction

Denise Pretzer, an accomplished inventor based in Chesterfield, Missouri, has made significant strides in the field of pharmaceutical innovations. With her expertise, she has focused on developing solutions that cater to patients with swallowing difficulties, specifically targeting bone health therapies.

Latest Patents

Denise Pretzer holds a patent for a novel oral liquid formulation of alendronate, a medication essential in treating and preventing bone loss. This innovative therapy protocol ensures that patients who struggle with swallowing can easily ingest the medication in a liquid form. Her patent details various pharmaceutical dosage forms, including syrup, aqueous solution, and reconstituted powder formulations, aimed at improving the therapeutic experience for patients.

Career Highlights

Throughout her career, Denise Pretzer has demonstrated a commitment to enhancing patient care through her research and inventions. Her role at Merck & Company, Inc. has allowed her to collaborate with esteemed professionals in the field, enabling the development of impactful treatment solutions.

Collaborations

Denise has worked alongside notable colleagues, including Gerald S. Brenner and Ashok V. Katdare. Their combined expertise has fostered a collaborative environment that promotes innovative advancements in pharmaceutical sciences, particularly in the realm of medications for bone health.

Conclusion

Denise Pretzer exemplifies the spirit of innovation within the pharmaceutical industry. Her dedication to creating effective oral liquid formulations for patients with swallowing challenges showcases her commitment to improving healthcare outcomes. With her unique contributions and collaborative efforts, she continues to pave the way for better therapeutic solutions in the field of bone health.